Why Moderna Shot 5%-Plus Higher on Thursday
Moderna (NASDAQ: MRNA) was a strong performer Thursday, rising to close 5.1% higher. Two pieces of good news from across the Pacific Ocean formed a bullish wave lifting the shares skyward.
The first, and more direct, of the two came from Japan's Health Ministry. An expert panel at the ministry formally recommended that the government approve Moderna's mRNA-1273 coronavirus vaccine for use in the populous Asian nation. Health Minister Norihisa Tamura said that such a nod could come on Friday -- a likely scenario given there's little time to waste in what's still a significant global healthcare crisis.
Image source: Getty Images.
Source Fool.com
